Joseph R. Young - May 15, 2024 Form 4 Insider Report for Vera Therapeutics, Inc. (VERA)

Role
SVP, FINANCE, CHIEF ACCT OFFCR
Signature
/s/ Joseph R. Young
Stock symbol
VERA
Transactions as of
May 15, 2024
Transactions value $
-$1,109,525
Form type
4
Date filed
5/17/2024, 04:21 PM
Previous filing
Apr 12, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction VERA Class A Common Stock Options Exercise $32.4K +8.22K +15.46% $3.94 61.4K May 15, 2024 Direct
transaction VERA Class A Common Stock Sale -$347K -8.22K -13.39% $42.17 53.2K May 15, 2024 Direct
transaction VERA Class A Common Stock Sale -$83.9K -1.97K -3.7% $42.68 51.2K May 15, 2024 Direct
transaction VERA Class A Common Stock Options Exercise $143K +18.2K +35.45% $7.87 69.4K May 16, 2024 Direct
transaction VERA Class A Common Stock Sale -$766K -18.2K -26.17% $42.22 51.2K May 16, 2024 Direct F1
transaction VERA Class A Common Stock Options Exercise $19.7K +2.5K +4.88% $7.87 53.7K May 16, 2024 Direct
transaction VERA Class A Common Stock Sale -$108K -2.5K -4.65% $43.03 51.2K May 16, 2024 Direct F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction VERA Stock Option (right to buy) Options Exercise $0 -8.22K -12.31% $0.00 58.6K May 15, 2024 Class A Common Stock 8.22K $3.94 Direct F3
transaction VERA Stock Option (right to buy) Options Exercise $0 -20.7K -22.95% $0.00 69.3K May 16, 2024 Class A Common Stock 20.7K $7.87 Direct F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The price reported is a weighted-average price. These shares were sold in multiple transactions at prices ranging from $42.00 to $42.86, inclusive. The Reporting Person will provide upon request to the staff of the Securities and Exchange Commission, the Issuer or any security holder of the Issuer, full information regarding the number of shares sold at each separate price.
F2 The price reported is a weighted-average price. These shares were sold in multiple transactions at prices ranging from $43.01 to $43.08, inclusive. The Reporting Person will provide upon request to the staff of the Securities and Exchange Commission, the Issuer or any security holder of the Issuer, full information regarding the number of shares sold at each separate price.
F3 1/4 of the shares subject to the option vested on March 9, 2022, and 1/48 of the shares vest monthly thereafter.
F4 1/48 of the total stock option vests and becomes exercisable monthly on the same day of each month following February 15, 2023, subject to continuous service of the Reporting Person on each vesting date.